Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Cools

Showing results (221-230 of 263) with videos related to

Pageof 27
Sort By:
Neuropsychologia|April 1, 1993
Impaired cognitive shifting in parkinsonian patients on anticholinergic therapyK P Van Spaendonck, H J Berger, M W Horstink, et al.
Brain Research|December 18, 2001
Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptorsM G Van Westerlaak, E A Joosten, A A Gribnau, et al.
Journal of Autism and Developmental Disorders|July 7, 2001
Cognitive styles in high-functioning adolescents with autistic disorderJ P Teunisse, A R Cools, K P van Spaendonck, et al.
Experimental Neurology|February 13, 2001
Chronic mitochondrial inhibition induces glutamate-mediated corticomotoneuron death in an organotypic culture modelM G Van Westerlaak, E A Joosten, A A Gribnau, et al.
Acta Neurologica Scandinavica|January 1, 1987
Cognitive performance in early Parkinson's diseaseK P van Spaendonck, H J Berger, M W Horstink, et al.
Behavioural Brain Research|June 30, 1993
Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in novelty-induced changes in hippocampal dynorphin B expression and two-way active avoidance: a new key in the search for the role of the hippocampal-accumbens axisA R Cools, J Dierx, C Coenders, et al.
Behavioural Pharmacology|April 26, 2000
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297G Andringa, R J Vermeulen, B Drukarch, et al.
Neuropsychologia|July 1, 1996
Executive functions and disease characteristics in Parkinson's diseaseK P Van Spaendonck, H J Berger, M W Horstink, et al.
Journal of Neurology|June 1, 1987
Spasmodic torticollis: the problem of pathophysiology and assessmentJ J van Hoof, M W Horstink, H J Berger, et al.
Psychopharmacology|April 2, 1999
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in ratsN M de Bruin, B A Ellenbroek, A R Cools, et al.
Pageof 27

Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
Neuropsychologia|April 1, 1993
Impaired cognitive shifting in parkinsonian patients on anticholinergic therapyK P Van Spaendonck, H J Berger, M W Horstink, et al.
Brain Research|December 18, 2001
Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptorsM G Van Westerlaak, E A Joosten, A A Gribnau, et al.
Journal of Autism and Developmental Disorders|July 7, 2001
Cognitive styles in high-functioning adolescents with autistic disorderJ P Teunisse, A R Cools, K P van Spaendonck, et al.
Experimental Neurology|February 13, 2001
Chronic mitochondrial inhibition induces glutamate-mediated corticomotoneuron death in an organotypic culture modelM G Van Westerlaak, E A Joosten, A A Gribnau, et al.
Acta Neurologica Scandinavica|January 1, 1987
Cognitive performance in early Parkinson's diseaseK P van Spaendonck, H J Berger, M W Horstink, et al.
Behavioural Brain Research|June 30, 1993
Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in novelty-induced changes in hippocampal dynorphin B expression and two-way active avoidance: a new key in the search for the role of the hippocampal-accumbens axisA R Cools, J Dierx, C Coenders, et al.
Behavioural Pharmacology|April 26, 2000
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297G Andringa, R J Vermeulen, B Drukarch, et al.
Neuropsychologia|July 1, 1996
Executive functions and disease characteristics in Parkinson's diseaseK P Van Spaendonck, H J Berger, M W Horstink, et al.
Journal of Neurology|June 1, 1987
Spasmodic torticollis: the problem of pathophysiology and assessmentJ J van Hoof, M W Horstink, H J Berger, et al.
Psychopharmacology|April 2, 1999
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in ratsN M de Bruin, B A Ellenbroek, A R Cools, et al.
Pageof 27